Use of transcriptional signatures induced in lymphoid and myeloid cell lines as an inflammatory biomarker in type 1 diabetes

Physiological Genomics

Volumn 43, Issue 11, 2011, Pages 697-709

  Jia, Shuang ^a   Kaldunski, Mary ^a   Jailwala, Parthav ^a   Geoffrey, Rhonda ^a   Kramer, Joanna ^a   Wang, Xujing ^b   Hessner, Martin J ^a  

^a CHILDREN S HOSPITAL OF WISCONSIN   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

Cytokines; Gene expression analysis; NCI60 leukemia cell lines

Indexed keywords

BIOLOGICAL MARKER; CYTOKINE;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ACUTE MONOCYTIC LEUKEMIA; ADULT; ARTICLE; BONE MARROW CULTURE; CAUCASIAN; CELL CULTURE; CELL STRAIN HL 60; CELL STRAIN K 562; CELL STRAIN U937; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; ERYTHROLEUKEMIA; FEMALE; HISTIOCYTIC LYMPHOMA; HUMAN; HUMAN CELL; INFLAMMATION; INSULIN DEPENDENT DIABETES MELLITUS; LEUKEMIA CELL LINE; LYMPHOID CELL LINE; MALE; MULTIPLE MYELOMA; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROMYELOCYTIC LEUKEMIA;

BIOLOGICAL MARKERS; CELL LINE, TUMOR; DIABETES MELLITUS, TYPE 1; GENE EXPRESSION PROFILING; HUMANS; INFLAMMATION MEDIATORS; LEUKEMIA; LEUKOCYTES, MONONUCLEAR; LYMPHOMA;

EID: 79959300845     PISSN: 10948341     EISSN: 15312267     Source Type: Journal    
DOI: 10.1152/physiolgenomics.00235.2010     Document Type: Article

References (62)

1. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 15: 539-553, 1998.
2. Atkinson MA, Eisenbarth GS. Type 1 diabetes: new perspectives on disease pathogenesis and treatment. Lancet 358: 221-229, 2001.
3. Axelsson S, Faresjo M, Hedman M, Ludvigsson J, Casas R. Cryopre-served peripheral blood mononuclear cells are suitable for the assessment of immunological markers in type 1 diabetic children. Cryobiology 57: 201-208, 2008.
4. Baekkeskov S, Aanstoot HJ, Christgau S, Reetz A, Solimena M, Cascalho M, Folli F, Richter-Olesen H, De Camilli P. Identification of the 64K autoantigen in insulin-dependent diabetes as the GABA-synthe-sizing enzyme glutamic acid decarboxylase. Nature 347: 151-156, 1990.
5. Beharka AA, Meydani M, Wu D, Leka LS, Meydani A, Meydani SN. Interleukin-6 production does not increase with age. J Gerontol A Biol Sci Med Sci 56: B81-B88, 2001.
6. Belov L, de la Vega O, dos Remedios CG, Mulligan SP, Christopherson RI. Immunophenotyping of leukemias using a cluster of differentiation antibody microarray. Cancer Res 61: 4483-4489, 2001.
7. Berdat PA, Wehrle TJ, Kung A, Achermann F, Sutter M, Carrel TP, Nydegger UE. Age-specific analysis of normal cytokine levels in healthy infants. Clin Chem Lab Med 41: 1335-1339, 2003.
8. Berges C, Naujokat C, Tinapp S, Wieczorek H, Hoh A, Sadeghi M, Opelz G, Daniel V. A cell line model for the differentiation of human dendritic cells. Biochem Biophys Res Commun 333: 896-907, 2005.
9. Bingley PJ, Bonifacio E, Williams AJ, Genovese S, Bottazzo GF, Gale EA. Prediction of IDDM in the general population: strategies based on combinations of autoantibody markers. Diabetes 46: 1701-1710, 1997.
10. Chen J, Bardes EE, Aronow BJ, Jegga AG. ToppGene Suite for gene list enrichment analysis and candidate gene prioritization. Nucleic Acids Res 37: W305-W311, 2009.
11. Chen J, Xu H, Aronow BJ, Jegga AG. Improved human disease candidate gene prioritization using mouse phenotype. BMC Bioinformatics 8: 392, 2007.
12. Collins SJ, Ruscetti FW, Gallagher RE, Gallo RC. Terminal differentiation of human promyelocytic leukemia cells induced by dimethyl sulfoxide and other polar compounds. Proc Natl Acad Sci USA 75: 2458-2462, 1978.
13. Dennis G Jr, Sherman BT, Hosack DA, Yang J, Gao W, Lane HC, Lempicki RA. DAVID: Database for Annotation, Visualization, and Integrated Discovery. Genome Biol 4: P3, 2003.
14. Devendra D, Liu E, Eisenbarth GS. Type 1 diabetes: recent developments. BMJ 328: 750-754, 2004.
15. Dogan Y, Akarsu S, Ustundag B, Yilmaz E, Gurgoze MK. Serum IL-1beta, IL-2, and IL-6 in insulin-dependent diabetic children. Med Inf (Lond) 2006: 59206, 2006.
16. Drexler HG, Matsuo AY, MacLeod RA. Continuous hematopoietic cell lines as model systems for leukemia-lymphoma research. Leuk Res 24: 881-911, 2000.
17. Drexler HG, Matsuo Y. Malignant hematopoietic cell lines: in vitro models for the study of multiple myeloma and plasma cell leukemia. Leuk Res 24: 681-703, 2000.
18. Drexler HG, Matsuo Y. Malignant hematopoietic cell lines: in vitro models for the study of natural killer cell leukemia-lymphoma. Leukemia 14: 777-782, 2000.
19. Edgar R, Domrachev M, Lash AE. Gene Expression Omnibus: NCBI gene expression and hybridization array data repository. Nucl Acids Res 30: 207-210, 2002.
20. Erbagci AB, Tarakcioglu M, Coskun Y, Sivasli E, Sibel Namiduru E. Mediators of inflammation in children with type I diabetes mellitus: cytokines in type I diabetic children. Clin Biochem 34: 645-650, 2001.
21. Fahey JL, Buell DN, Sox HC. Proliferation and differentiation of lym-phoid cells: studies with human lymphoid cell lines and immunoglobulin synthesis. Ann NY Acad Sci 190: 221-234, 1971.
22. Green EA, Flavell RA. The temporal importance of TNFalpha expression in the development of diabetes. Immunity 12: 459-469, 2000.
23. Guerder S, Picarella DE, Linsley PS, Flavell RA. Costimulator B7-1 confers antigen-presenting-cell function to parenchymal tissue and in conjunction with tumor necrosis factor alpha leads to autoimmunity in transgenic mice. Proc Natl Acad Sci USA 91: 5138-5142, 1994.
24. Hasegawa Y, Sawada M, Ozaki N, Inagaki T, Suzumura A. Increased soluble tumor necrosis factor receptor levels in the serum of elderly people. Gerontology 46: 185-188, 2000.
25. Hong F, Breitling R, McEntee CW, Wittner BS, Nemhauser JL, Chory J. RankProd: a bioconductor package for detecting differentially expressed genes in meta-analysis. Bioinformatics 22: 2825-2827, 2006.
26. Hosack DA, Dennis G Jr, Sherman BT, Lane HC, Lempicki RA. Identifying biological themes within lists of genes with EASE. Genome Biol 4: R70, 2003.
27. Hussain MJ, Peakman M, Gallati H, Lo SS, Hawa M, Viberti GC, Watkins PJ, Leslie RD, Vergani D. Elevated serum levels of macro-phage-derived cytokines precede and accompany the onset of IDDM. Diabetologia 39: 60-69, 1996.
28. Imagawa A, Hanafusa T, Itoh N, Miyagawa J, Nakajima H, Namba M, Kuwajima M, Tamura S, Kawata S, Matsuzawa Y, Harlan DM. Islet-infiltrating t lymphocytes in insulin-dependent diabetic patients express CD80 (B7-1) and CD86 (B7-2). J Autoimmun 9: 391-396, 1996.
29. Imagawa A, Hanafusa T, Itoh N, Waguri M, Yamamoto K, Miyagawa J, Moriwaki M, Yamagata K, Iwahashi H, Sada M, Tsuji T, Tamura S, Kawata S, Kuwajima M, Nakajima H, Namba M, Matsuzawa Y. Immunological abnormalities in islets at diagnosis paralleled further deterioration of glycaemic control in patients with recent-onset Type I (insulin-dependent) diabetes mellitus. Diabetologia 42: 574-578, 1999.
30. Imagawa A, Hanafusa T, Tamura S, Moriwaki M, Itoh N, Yamamoto K, Iwahashi H, Yamagata K, Waguri M, Nanmo T, Uno S, Nakajima H, Namba M, Kawata S, Miyagawa JI, Matsuzawa Y. Pancreatic biopsy as a procedure for detecting in situ autoimmune phenomena in type 1 diabetes: close correlation between serological markers and histological evidence of cellular autoimmunity. Diabetes 50: 1269-1273, 2001.
31. Kaizer EC, Glaser CL, Chaussabel D, Banchereau J, Pascual V, White PC. Gene expression in peripheral blood mononuclear cells from children with diabetes. J Clin Endocrinol Metab 92: 3705-3711, 2007.
32. Kaldunski M, Jia S, Geoffrey R, Basken J, Prosser S, Kansra S, Mordes JP, Lernmark A, Wang X, Hessner MJ. Identification of a serum-induced transcriptional signature associated with type 1 diabetes in the BioBreeding rat. Diabetes 59: 2375-2385, 2010.
33. Klein E, Ben-Bassat H, Neumann H, Ralph P, Zeuthen J, Polliack A, Vanky F. Properties of the K562 cell line, derived from a patient with chronic myeloid leukemia. Int J Cancer 18: 421-431, 1976.
34. Klitz W, Maiers M, Spellman S, Baxter-Lowe LA, Schmeckpeper B, Williams TM, Fernandez-Vina M. New HLA haplotype frequency reference standards: high-resolution and large sample typing of HLA DR-DQ haplotypes in a sample of European Americans. Tissue Antigens 62: 296-307, 2003.
35. Koeffler HP, Golde DW. Acute myelogenous leukemia: a human cell line responsive to colony-stimulating activity. Science 200: 1153-1154, 1978.
36. Kreher CR, Dittrich MT, Guerkov R, Boehm BO, Tary-Lehmann M. CD4+ and CD8+ cells in cryopreserved human PBMC maintain full functionality in cytokine ELISPOT assays. J Immunol Methods 278: 79-93, 2003.
37. Kubo M, Cinader B. IL-3 production as a function of age and its correlation with splenomegaly: age versus disease-related change. Immunol Lett 24: 133-136, 1990.
38. Lozzio BB, Lozzio CB. Properties and usefulness of the original K-562 human myelogenous leukemia cell line. Leuk Res 3: 363-370, 1979.
39. Martin S, Wolf-Eichbaum D, Duinkerken G, Scherbaum WA, Kolb H, Noordzij JG, Roep BO. Development of type 1 diabetes despite severe hereditary B-lymphocyte deficiency. N Engl J Med 345: 1036-1040, 2001.
40. Moos PJ, Raetz EA, Carlson MA, Szabo A, Smith FE, Willman C, Wei Q, Hunger SP, Carroll WL. Identification of gene expression profiles that segregate patients with childhood leukemia. Clin Cancer Res 8: 3118-3130, 2002.
41. Nicoletti F, Conget I, Di Marco R, Speciale AM, Morinigo R, Bendt-zen K, Gomis R. Serum levels of the interferon-gamma-inducing cytokine interleukin-18 are increased in individuals at high risk of developing type I diabetes. Diabetologia 44: 309-311, 2001.
42. Nicoletti F, Conget I, Di Mauro M, Di Marco R, Mazzarino MC, Bendtzen K, Messina A, Gomis R. Serum concentrations of the inter-feron-gamma-inducible chemokine IP-10/CXCL10 are augmented in both newly diagnosed Type I diabetes mellitus patients and subjects at risk of developing the disease. Diabetologia 45: 1107-1110, 2002.
43. Olsson I, Gullberg U, Ivhed I, Nilsson K. Induction of differentiation of the human histiocytic lymphoma cell line U-937 by 1 alpha,25-dihydroxy-cholecalciferol. Cancer Res 43: 5862-5867, 1983.
44. Ortaldo JR, Oldham RK, Cannon GC, Herberman RB. Specificity of natural cytotoxic reactivity of normal human lymphocytes against a myeloid leukemia cell line. J Natl Cancer Inst 59: 77-82, 1977.
45. Pascual V, Allantaz F, Arce E, Punaro M, Banchereau J. Role of interleukin-1 (IL-1) in the pathogenesis of systemic onset juvenile idiopathic arthritis and clinical response to IL-1 blockade. J Exp Med 201: 1479-1486, 2005.
46. Pascual V, Chaussabel D, Banchereau J. A genomic approach to human autoimmune diseases. Ann Rev Immunol 28: 535-571.
47. Pellat-Deceunynk C, Amiot M, Bataille R, Van Riet I, Van Camp B, Omede P, Boccadoro M. Human myeloma cell lines as a tool for studying the biology of multiple myeloma: a reappraisal 18 years after. Blood 86: 4001-4002, 1995.
48. Perez F, Oyarzun A, Carrasco E, Angel B, Albala C, Santos JL. [Plasma levels of interleukin-1beta, interleukin-2 and interleukin-4 in recently diagnosed type 1 diabetic children and their association with beta-pancreatic autoantibodies]. Rev Med Chil 132: 413-420, 2004.
49. Reiss CS, Hemler ME, Englehard VH, Mier JW, Strominger JL, Burakoff SJ. Development and characterization of allospecific long-term human cytolytic T-cell lines. Proc Natl Acad Sci USA 77: 5432-5436, 1980.
50. Ross DT, Scherf U, Eisen MB, Perou CM, Rees C, Spellman P, Iyer V, Jeffrey SS, Van de Rijn M, Waltham M, Pergamenschikov A, Lee JC, Lashkari D, Shalon D, Myers TG, Weinstein JN, Botstein D, Brown PO. Systematic variation in gene expression patterns in human cancer cell lines. Nat Genet 24: 227-235, 2000.
51. Ross ME, Zhou X, Song G, Shurtleff SA, Girtman K, Williams WK, Liu HC, Mahfouz R, Raimondi SC, Lenny N, Patel A, Downing JR. Classification of pediatric acute lymphoblastic leukemia by gene expression profiling. Blood 102: 2951-2959, 2003.
52. Sandstrom PA, Buttke TM. Autocrine production of extracellular cata-lase prevents apoptosis of the human CEM T-cell line in serum-free medium. Proc Natl Acad Sci USA 90: 4708-4712, 1993.
53. Schultz C, Rott C, Temming P, Schlenke P, Moller JC, Bucsky P. Enhanced interleukin-6 and interleukin-8 synthesis in term and preterm infants. Pediatr Res 51: 317-322, 2002.
54. Shimabukuro M, Koyama K, Lee Y, Unger RH. Leptin- or troglitazone-induced lipopenia protects islets from interleukin 1beta cytotoxicity. J Clin Invest 100: 1750-1754, 1997.
55. Skyler JS. Prediction and prevention of type 1 diabetes: progress, problems, and prospects. Clin Pharmacol Ther 81: 768-771, 2007.
56. Sobota V, Bubenik J, Indrova M, Vlk V, Jakoubkova J. Use of cryopreserved lymphocytes for assessment of the immunological effects of interferon therapy in renal cell carcinoma patients. J Immunol Methods 203: 1-10, 1997.
57. St Louis DC, Woodcock JB, Franzoso G, Blair PJ, Carlson LM, Murillo M, Wells MR, Williams AJ, Smoot DS, Kaushal S, Grimes JL, Harlan DM, Chute JP, June CH, Siebenlist U, Lee KP. Evidence for distinct intracellular signaling pathways in CD34+ progenitor to dendritic cell differentiation from a human cell line model. J Immunol 162: 3237-3248, 1999.
58. Sturn A, Quackenbush J, Trajanoski Z. Genesis: cluster analysis of microarray data. Bioinformatics 18: 207-208, 2002.
59. Wang SY, Hsu ML, Tzeng CH, Hsu HC, Ho CK. The influence of cryopreservation on cytokine production by human T lymphocytes. Cryo-biology 37: 22-29, 1998.
60. Wang X, Jia S, Geoffrey R, Alemzadeh R, Ghosh S, Hessner MJ. Identification of a molecular signature in human type 1 diabetes mellitus using serum and functional genomics. J Immunol 180: 1929-1937, 2008.
61. Woo W, LaGasse JM, Zhou Z, Patel R, Palmer JP, Campus H, Hagopian WA. A novel high-throughput method for accurate, rapid, and economical measurement of multiple type 1 diabetes autoantibodies. J Immunol Methods 244: 91-103, 2000.
62. Yeoh EJ, Ross ME, Shurtleff SA, Williams WK, Patel D, Mahfouz R, Behm FG, Raimondi SC, Relling MV, Patel A, Cheng C, Campana D, Wilkins D, Zhou X, Li J, Liu H, Pui CH, Evans WE, Naeve C, Wong L, Downing JR. Classification, subtype discovery, and prediction of outcome in pediatric acute lymphoblastic leukemia by gene expression profiling. Cancer Cell 1: 133-143, 2002.